Oramed Pharmaceuticals Inc. (ORMP): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2013-08-31, 2014-08-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2014-08-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$5.90M
Year ended 2014-08-31
$4.31M2012-08-31: -$2.87M2013-08-31: $4.31M2014-08-31: -$5.90M-$5.90M
2012-08-31 EBITDA (USD) 2014-08-31
Period endedEBITDAChange YoYSource filing
2014-08-31-$5.90Mn/c2016-11-25, From 2013-09-01
2013-08-31$4.31Mn/c2015-11-25, From 2012-09-01
2012-08-31-$2.87Mn/a2014-11-14, From 2011-09-01